{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:12:47Z","timestamp":1784769167200,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10238-019-00578-3","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T20:04:27Z","timestamp":1567627467000},"page":"487-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["NK and NKT-like cells in granulomatous and fibrotic lung diseases"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-3223","authenticated-orcid":false,"given":"L","family":"Bergantini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Cameli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"d\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Vagaggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RM","family":"Refini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Landi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MG","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Spalletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sestini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Bargagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,4]]},"reference":[{"issue":"5","key":"578_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","volume":"19","author":"KL O\u2019Brien","year":"2019","unstructured":"O\u2019Brien KL, Finlay DK. Immunometabolism and natural killer cell responses. Nat Rev Immunol. 2019;19(5):282\u201390. \n                    https:\/\/doi.org\/10.1038\/s41577-019-0139-2\n                    \n                  .","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"578_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41423-019-0212-6","volume":"16","author":"X Wang","year":"2019","unstructured":"Wang X, Peng H, Tian Z. Innate lymphoid cell memory. Cell Mol Immunol. 2019;16(5):423\u20139. \n                    https:\/\/doi.org\/10.1038\/s41423-019-0212-6\n                    \n                  .","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"578_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","volume":"16","author":"S Sivori","year":"2019","unstructured":"Sivori S, Vacca P, Del Zotto G, Munari E, Mingari MC, Moretta L, Human NK. Cells: surface receptors, inhibitory checkpoints, and translational applications. Cell Mol Immunol. 2019;16(5):430\u201341. \n                    https:\/\/doi.org\/10.1038\/s41423-019-0206-4\n                    \n                  .","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"578_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10238-019-00564-9","volume":"19","author":"H-J Jiang","year":"2019","unstructured":"Jiang H-J, Wang X-X, Luo B-F, et al. Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients. Clin Exp Med. 2019;19(3):299\u2013308. \n                    https:\/\/doi.org\/10.1007\/s10238-019-00564-9\n                    \n                  .","journal-title":"Clin Exp Med"},{"issue":"2","key":"578_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10238-014-0278-5","volume":"15","author":"VR Parasa","year":"2015","unstructured":"Parasa VR, Selvaraj A, Sikhamani R, Raja A. Interleukins 15 and 12 in combination expand the selective loss of natural killer T cells in HIV infection in vitro. Clin Exp Med. 2015;15(2):205\u201313. \n                    https:\/\/doi.org\/10.1007\/s10238-014-0278-5\n                    \n                  .","journal-title":"Clin Exp Med"},{"issue":"2","key":"578_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10238-011-0151-8","volume":"12","author":"TD Shi","year":"2012","unstructured":"Shi TD, Zhang JM, Wang XF, et al. Effects of antiviral therapy with Telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients. Clin Exp Med. 2012;12(2):105\u201313. \n                    https:\/\/doi.org\/10.1007\/s10238-011-0151-8\n                    \n                  .","journal-title":"Clin Exp Med"},{"key":"578_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91954","author":"JC Yu","year":"2018","unstructured":"Yu JC, Lin G, Field JJ, Linden J. Induction of antiinflammatory purinergic signaling in activated human iNKT cells. JCI Insight. 2018. \n                    https:\/\/doi.org\/10.1172\/jci.insight.91954\n                    \n                  .","journal-title":"JCI Insight"},{"key":"578_CR8","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.3389\/fimmu.2018.03101","volume":"9","author":"B Stankovic","year":"2018","unstructured":"Stankovic B, Bj\u00f8rhovde HAK, Skarshaug R, et al. Immune cell composition in human non-small cell lung cancer. Front Immunol. 2018;9:3101. \n                    https:\/\/doi.org\/10.3389\/fimmu.2018.03101\n                    \n                  .","journal-title":"Front Immunol"},{"issue":"1","key":"578_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12931-018-0940-7","volume":"19","author":"J Eriksson Str\u00f6m","year":"2018","unstructured":"Eriksson Str\u00f6m J, Pourazar J, Linder R, et al. Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking. Respir Res. 2018;19(1):244. \n                    https:\/\/doi.org\/10.1186\/s12931-018-0940-7\n                    \n                  .","journal-title":"Respir Res"},{"issue":"4","key":"578_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10238-012-0199-0","volume":"13","author":"J Novak","year":"2013","unstructured":"Novak J, Novakova L. Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells. Clin Exp Med. 2013;13(4):229\u201337. \n                    https:\/\/doi.org\/10.1007\/s10238-012-0199-0\n                    \n                  .","journal-title":"Clin Exp Med"},{"issue":"1","key":"578_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10238-015-0402-1","volume":"17","author":"Y-L Lin","year":"2017","unstructured":"Lin Y-L, Lin S-C. Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients. Clin Exp Med. 2017;17(1):101\u20139. \n                    https:\/\/doi.org\/10.1007\/s10238-015-0402-1\n                    \n                  .","journal-title":"Clin Exp Med"},{"key":"578_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1600-065X.2007.00563.x","volume":"220","author":"C Gr\u00e9goire","year":"2007","unstructured":"Gr\u00e9goire C, Chasson L, Luci C, et al. The trafficking of natural killer cells. Immunol Rev. 2007;220:169\u201382. \n                    https:\/\/doi.org\/10.1111\/j.1600-065X.2007.00563.x\n                    \n                  .","journal-title":"Immunol Rev"},{"issue":"1","key":"578_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2567.2012.03607.x","volume":"137","author":"J Wang","year":"2012","unstructured":"Wang J, Li F, Zheng M, Sun R, Wei H, Tian Z. Lung natural killer cells in mice: phenotype and response to respiratory infection. Immunology. 2012;137(1):37\u201347. \n                    https:\/\/doi.org\/10.1111\/j.1365-2567.2012.03607.x\n                    \n                  .","journal-title":"Immunology"},{"issue":"2","key":"578_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/cei.13219","volume":"195","author":"D Riemann","year":"2019","unstructured":"Riemann D, Cwikowski M, Turzer S, et al. Blood immune cell biomarkers in lung cancer. Clin Exp Immunol. 2019;195(2):179\u201389. \n                    https:\/\/doi.org\/10.1111\/cei.13219\n                    \n                  .","journal-title":"Clin Exp Immunol"},{"key":"578_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061511","author":"G Hodge","year":"2019","unstructured":"Hodge G, Hodge S. Therapeutic targeting steroid resistant pro-inflammatory NK and NKT-like cells in chronic inflammatory lung disease. Int J Mol Sci. 2019. \n                    https:\/\/doi.org\/10.3390\/ijms20061511\n                    \n                  .","journal-title":"Int J Mol Sci"},{"key":"578_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002545","author":"CM Harpur","year":"2018","unstructured":"Harpur CM, Stankovic S, Kanagarajah A, et al. Enrichment of cytomegalovirus-induced NKG2C\u2009+\u2009natural killer cells in the lung allograft. Transplantation. 2018. \n                    https:\/\/doi.org\/10.1097\/TP.0000000000002545\n                    \n                  .","journal-title":"Transplantation"},{"issue":"4","key":"578_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/thoraxjnl-2018-212345","volume":"74","author":"DR Calabrese","year":"2019","unstructured":"Calabrese DR, Lanier LL, Greenland JR. Natural killer cells in lung transplantation. Thorax. 2019;74(4):397\u2013404. \n                    https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212345\n                    \n                  .","journal-title":"Thorax"},{"issue":"3","key":"578_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18030616","volume":"18","author":"P Souza-Fonseca-Guimaraes","year":"2017","unstructured":"Souza-Fonseca-Guimaraes P, Guimaraes F, Nat\u00e2nia De Souza-Araujo C, et al. Natural killer cell assessment in peripheral circulation and bronchoalveolar lavage fluid of patients with severe sepsis: a case control study. Int J Mol Sci. 2017;18(3):1\u20132. \n                    https:\/\/doi.org\/10.3390\/ijms18030616\n                    \n                  .","journal-title":"Int J Mol Sci"},{"issue":"6","key":"578_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/mi.2013.59","volume":"6","author":"C Paget","year":"2013","unstructured":"Paget C, Trottein F. Role of type 1 natural killer T cells in pulmonary immunity. Mucosal Immunol. 2013;6(6):1054\u201367. \n                    https:\/\/doi.org\/10.1038\/mi.2013.59\n                    \n                  .","journal-title":"Mucosal Immunol"},{"issue":"1","key":"578_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1183\/09031936.05.00030805","volume":"26","author":"K Katchar","year":"2005","unstructured":"Katchar K, S\u00f6derstr\u00f6m K, Wahlstrom J, Eklund A, Grunewald J. Characterisation of natural killer cells and CD56\u2009+\u2009T-cells in sarcoidosis patients. Eur Respir J. 2005;26(1):77\u201385. \n                    https:\/\/doi.org\/10.1183\/09031936.05.00030805\n                    \n                  .","journal-title":"Eur Respir J"},{"issue":"2","key":"578_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.imlet.2014.12.004","volume":"163","author":"IC Papanikolaou","year":"2015","unstructured":"Papanikolaou IC, Boki KA, Giamarellos-Bourboulis EJ, et al. Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases. Immunol Lett. 2015;163(2):179\u201386. \n                    https:\/\/doi.org\/10.1016\/j.imlet.2014.12.004\n                    \n                  .","journal-title":"Immunol Lett"},{"key":"578_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-019-0802-1","volume":"19","author":"O Sokhatska","year":"2019","unstructured":"Sokhatska O, Padr\u00e3o E, Sousa-Pinto B, et al. NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis. BMC Pulm Med. 2019;19:1\u20132. \n                    https:\/\/doi.org\/10.1186\/s12890-019-0802-1\n                    \n                  .","journal-title":"BMC Pulm Med"},{"issue":"6","key":"578_CR23","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, et al. An official american thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348. \n                    https:\/\/doi.org\/10.1164\/rccm.201308-1483ST\n                    \n                  .","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"578_CR24","first-page":"149","volume":"16","author":"GW Hunninghake","year":"1999","unstructured":"Hunninghake GW, Costabel U, Ando M, et al. ATS\/ERS\/WASOG statement on sarcoidosis. American thoracic society\/European respiratory society\/World association of sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG. 1999;16(2):149\u201373.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"issue":"8","key":"578_CR25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1164\/rccm.201710-1986OC","volume":"197","author":"J Morisset","year":"2018","unstructured":"Morisset J, Johannson KA, Jones KD, et al. Identification of diagnostic criteria for chronic hypersensitivity pneumonitis: an international modified delphi survey. Am J Respir Crit Care Med. 2018;197(8):1036\u201344. \n                    https:\/\/doi.org\/10.1164\/rccm.201710-1986OC\n                    \n                  .","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"578_CR26","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1164\/rccm.201710-1981st","volume":"196","author":"BH Culver","year":"2017","unstructured":"Culver BH, Graham BL, Coates AL, et al. Recommendations for a standardized pulmonary function report. An official American thoracic society technical statement. Am J Respir Crit Care Med. 2017;196(11):1463\u201372. \n                    https:\/\/doi.org\/10.1164\/rccm.201710-1981st\n                    \n                  .","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"578_CR27","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer KC, Raghu G, Baughman RP, et al. An official American thoracic society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004\u201314. \n                    https:\/\/doi.org\/10.1164\/rccm.201202-0320ST\n                    \n                  .","journal-title":"Am J Respir Crit Care Med"},{"key":"578_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jprot.2015.08.012","volume":"128","author":"C Landi","year":"2015","unstructured":"Landi C, Bargagli E, Carleo A, et al. A functional proteomics approach to the comprehension of sarcoidosis. J Proteomics. 2015;128:375\u201387. \n                    https:\/\/doi.org\/10.1016\/j.jprot.2015.08.012\n                    \n                  .","journal-title":"J Proteomics"},{"key":"578_CR29","doi-asserted-by":"publisher","first-page":"8565423","DOI":"10.1155\/2019\/8565423","volume":"2019","author":"L Bergantini","year":"2019","unstructured":"Bergantini L, Bianchi F, Cameli P, et al. Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, Lysozyme, and KL-6. Dis Mark. 2019;2019:8565423. \n                    https:\/\/doi.org\/10.1155\/2019\/8565423\n                    \n                  .","journal-title":"Dis Mark"},{"issue":"3","key":"578_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11739-017-1778-6","volume":"13","author":"E Bargagli","year":"2018","unstructured":"Bargagli E, Prasse A. Sarcoidosis: a review for the internist. Int Emerg Med. 2018;13(3):325\u201331. \n                    https:\/\/doi.org\/10.1007\/s11739-017-1778-6\n                    \n                  .","journal-title":"Int Emerg Med"},{"issue":"4","key":"578_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/JLB.5A0718-280RR","volume":"105","author":"R Lepzien","year":"2019","unstructured":"Lepzien R, Rankin G, Pourazar J, et al. Mapping mononuclear phagocytes in blood, lungs, and lymph nodes of sarcoidosis patients. J Leukoc Biol. 2019;105(4):797\u2013807. \n                    https:\/\/doi.org\/10.1002\/JLB.5A0718-280RR\n                    \n                  .","journal-title":"J Leukoc Biol"},{"issue":"2","key":"578_CR32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/0090-1229(85)90158-8","volume":"37","author":"C Agostini","year":"1985","unstructured":"Agostini C, Trentin L, Zambello R, et al. Phenotypical and functional analysis of natural killer cells in sarcoidosis. Clin Immunol Immunopathol. 1985;37(2):262\u201375.","journal-title":"Clin Immunol Immunopathol"},{"issue":"Suppl 1","key":"578_CR33","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/S0954-6111(11)70006-3","volume":"105","author":"M Rijavec","year":"2011","unstructured":"Rijavec M, Volarevic S, Osolnik K, Kosnik M, Korosec P. Natural killer T cells in pulmonary disorders. Respir Med. 2011;105(Suppl 1):S20\u20135. \n                    https:\/\/doi.org\/10.1016\/S0954-6111(11)70006-3\n                    \n                  .","journal-title":"Respir Med"},{"issue":"4","key":"578_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.rmed.2009.11.008","volume":"104","author":"P Korosec","year":"2010","unstructured":"Korosec P, Rijavec M, Silar M, Kern I, Kosnik M, Osolnik K. Deficiency of pulmonary Valpha24 Vbeta11 natural killer T cells in corticosteroid-na\u00efve sarcoidosis patients. Respir Med. 2010;104(4):571\u20137. \n                    https:\/\/doi.org\/10.1016\/j.rmed.2009.11.008\n                    \n                  .","journal-title":"Respir Med"},{"issue":"6","key":"578_CR35","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S1081-1206(10)60387-0","volume":"99","author":"J Temprano","year":"2007","unstructured":"Temprano J, Becker BA, Hutcheson PS, Knutsen AP, Dixit A, Slavin RG. Hypersensitivity pneumonitis secondary to residential exposure to Aureobasidium pullulans in 2 siblings. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2007;99(6):562\u20136. \n                    https:\/\/doi.org\/10.1016\/S1081-1206(10)60387-0\n                    \n                  .","journal-title":"Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol"},{"issue":"2","key":"578_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.pulmoe.2018.07.003","volume":"25","author":"R Nogueira","year":"2019","unstructured":"Nogueira R, Melo N, e Bastos HN, et al. Hypersensitivity pneumonitis: antigen diversity and disease implications. Pulmonology. 2019;25(2):97\u2013108. \n                    https:\/\/doi.org\/10.1016\/j.pulmoe.2018.07.003\n                    \n                  .","journal-title":"Pulmonology"},{"issue":"2","key":"578_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/path.2290","volume":"214","author":"R Boyton","year":"2008","unstructured":"Boyton R. The role of natural killer T cells in lung inflammation. J Pathol. 2008;214(2):276\u201382. \n                    https:\/\/doi.org\/10.1002\/path.2290\n                    \n                  .","journal-title":"J Pathol"},{"issue":"5","key":"578_CR38","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/resp.12305","volume":"19","author":"D Papakosta","year":"2014","unstructured":"Papakosta D, Manika K, Gounari E, et al. Bronchoalveolar lavage fluid and blood natural killer and natural killer T-like cells in cryptogenic organizing pneumonia. Respirol Carlton Vic. 2014;19(5):748\u201354. \n                    https:\/\/doi.org\/10.1111\/resp.12305\n                    \n                  .","journal-title":"Respirol Carlton Vic"},{"issue":"2","key":"578_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cyto.2013.12.003","volume":"66","author":"D Galati","year":"2014","unstructured":"Galati D, De Martino M, Trotta A, et al. Peripheral depletion of NK cells and imbalance of the Treg\/Th17 axis in idiopathic pulmonary fibrosis patients. Cytokine. 2014;66(2):119\u201326. \n                    https:\/\/doi.org\/10.1016\/j.cyto.2013.12.003\n                    \n                  .","journal-title":"Cytokine"},{"issue":"8","key":"578_CR40","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/art.40130","volume":"69","author":"NS Goh","year":"2017","unstructured":"Goh NS, Hoyles RK, Denton CP, et al. Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis. Arthritis Rheumatol. 2017;69(8):1670\u20138. \n                    https:\/\/doi.org\/10.1002\/art.40130\n                    \n                  .","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-019-00578-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-019-00578-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-019-00578-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T23:11:47Z","timestamp":1599088307000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-019-00578-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1007\/s10238-019-00578-3","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,4]]},"assertion":[{"value":"5 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (Local Ethics Committee C.E. A. V. S. E. (Code Number 180712) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}